Adjuvant therapy for resected non-small-cell lung cancer with lymphovascular invasion

Journal of Thoracic Oncology

Volumn 8, Issue 1, 2013, Pages

  Rami Porta, Ramón ^a  

^a HOSPITAL MÚTUA DE TERRASSA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURGERY; CLINICAL ASSESSMENT; CYTOLOGY; DISEASE ASSOCIATION; DISEASE SEVERITY; HIGH RISK PATIENT; HUMAN; LETTER; LONG TERM SURVIVAL; LUNG LAVAGE; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LYMPH VESSEL; LYMPH VESSEL METASTASIS; PERINEURIUM; PLEURA FLUID; PLEURA METASTASIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; TREATMENT OUTCOME; VISCERAL METASTASIS;

EID: 84871995676     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e3182797f3b     Document Type: Letter

References (5)

1. Salvati F. Lymphovascular invasion in non-small cell lung cancer. J Thorac Oncol 2013; 8:e8-e9.
2. Higgins KA, Chino J P, Ready N, et al. Lymphovascular invasion in non-small-cell lung cancer: implications for staging and adjuvant therapy. J Thorac Oncol 2012;7:1141-1147.
3. Goldstraw P (Ed)., Staging Manual in Thoracic Oncology. Orange Park, FL: Editorial Rx Press; 2009, Pp. 85-86.
4. Horn L, Sandler AB, Putnam JB Jr, Johnson DH. The rationale for adjuvant chemotherapy in stage I non-small cell lung cancer. J Thorac Oncol 2007;2:377-383.
5. Giroux DJ, Rami-Porta R, Chansky K, et al.; International Association for the Study of Lung Cancer International Staging Committee. The IASLC Lung Cancer Staging Project: data elements for the prospective project. J Thorac Oncol 2009;4:679-683.